According to Towards Healthcare Research and Consulting Reports China is rapidly transforming from a healthcare system focused on disease treatment to one increasingly centered on disease prediction and prevention.
Genetic testing, once limited to hospitals and research laboratories, is now reaching ordinary consumers seeking personalized insights into their health, nutrition, fitness, and disease risks.
This shift is creating strong demand for predictive genetic testing and consumer wellness genomics services across the country. China has become one of the world’s most active genomics markets thanks to large-scale investments in biotechnology, genome sequencing, and precision medicine initiatives.
Why Millions of Chinese Consumers Are Turning to DNA Testing
China faces a growing burden of chronic diseases.
According to government health statistics, chronic diseases account for more than 80% of deaths in China and nearly 70% of the total disease burden. Rising rates of cancer, diabetes, cardiovascular disease, and obesity are increasing interest in preventive healthcare.
Consumers increasingly want to know their genetic predisposition before symptoms appear.
Rather than waiting for illness, many individuals are using genetic tests to understand inherited risks and make lifestyle changes earlier. This preventive approach is becoming a major driver of consumer genomics adoption.
Government Support Is Accelerating the Genomics Revolution
The Chinese government has made genomics a strategic national priority.
Under the national precision medicine initiative, China committed billions of yuan to genomics research, population health studies, and biotechnology innovation. The country has also invested heavily in large-scale sequencing programs and genomic databases designed to improve disease prevention and personalized medicine.
China’s genome research infrastructure is now among the largest in the world, helping reduce sequencing costs and improve access to genetic testing services.
The Companies Leading China’s Consumer Genomics Industry
Several companies are shaping the country’s predictive genetic testing landscape.
BGI Genomics is China’s largest genomics company and one of the world’s largest DNA sequencing organizations. The company operates advanced sequencing facilities and has supported numerous national genomics initiatives. More than 8 million women globally have reportedly used BGI’s prenatal genetic testing services.
MGI Tech develops sequencing platforms and genomic technologies that help lower testing costs and expand access to genetic analysis.
Genetron Holdings focuses on precision oncology and molecular diagnostics, supporting cancer risk assessment and personalized treatment planning.
WuXi NextCODE provides genomic data interpretation and precision medicine solutions that support large-scale genetic analysis.
Consumer Wellness Genomics Is Becoming Mainstream
The market is no longer focused only on disease prediction.
Consumers are increasingly purchasing DNA-based wellness tests that provide personalized recommendations for nutrition, fitness, metabolism, sleep quality, skin health, and healthy aging.
Nutrigenomics has emerged as one of the fastest-growing segments as consumers seek customized dietary plans based on their genetic profiles. Health risk assessment remains the largest application area in China’s consumer genomics sector.
Key Market Statistics
| Indicator | Latest Available Data |
|---|---|
| China Consumer Genomics Market Value (2022) | USD 209.2 Million |
| China Predictive Genetic Testing & Wellness Genomics Market Value (2024) | USD 406.9 Million |
| Largest Application | Health Risk Assessment |
| Fastest Growing Segment | Nutrigenomics |
| Major End Users | Healthcare Providers, Diagnostic Labs, DTC Platforms |
| Leading Chinese Companies | BGI Genomics, MGI Tech, Genetron Holdings, WuXi NextCODE |
Data Privacy Is Becoming a Critical Issue
As genetic testing expands, the volume of genomic data being collected is growing rapidly.
Large-scale genomic databases are helping researchers identify disease patterns and improve precision medicine. However, they are also raising questions about data security, consent, and privacy protection.
Regulators are strengthening oversight of human genetic resource management to ensure genomic data is handled responsibly while supporting innovation.
The Future Is Personalized Healthcare
China’s predictive genetic testing and consumer wellness genomics industry represents a major shift in healthcare delivery.
Instead of relying solely on generalized health recommendations, consumers are increasingly seeking personalized insights based on their unique genetic makeup.
With strong government backing, advanced sequencing capabilities, expanding consumer awareness, and leading companies investing heavily in innovation, genomics is becoming an important part of China’s long-term healthcare strategy.
The result is a healthcare ecosystem where prevention, personalization, and precision are gradually becoming as important as treatment itself.
Get Easy Access
Access our exclusive, data-rich dashboard dedicated to the biotechnology industry – built specifically for decision-makers, strategists, and industry leaders. The dashboard features comprehensive statistical data, segment-wise market breakdowns, regional performance shares, detailed company profiles, annual updates, and much more. From market sizing to competitive intelligence, this powerful tool is one-stop solution to your gateway.
Access the Dashboard: https://www.towardshealthcare.com/access-dashboard
About Us
Healthcare WebWire is a part of Towards Healthcare Research and Consulting which is a global strategy and intelligence firm focused on the biotechnology sector. We partner with biotech companies and research organizations to support innovation across drug discovery, bioprocessing, and advanced therapeutics. Through deep scientific insight and market analytics, we help accelerate development timelines, optimize R&D strategies, and translate breakthrough science into commercially viable solutions.
You can place an order or ask any questions, please feel free to contact us at sales@towardshealthcare.com
Europe Region – +44 778 256 0738
North America Region – +1 8044 4193 44
APAC Region: +91 9356 9282 04
Visit Our Website: https://www.towardshealthcare.com
Find us on social platforms: LinkedIn | Twitter | Instagram | Medium